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CHARACTERIZATION OF A NON-ORIGINATOR NISTmAb EXPRESSION SYSTEM 
 




The successful development and regulatory approval of originator and biosimilar therapeutic proteins requires 
system approach to upstream and downstream processing as well as product characterization and quality 
control.  Innovation in process design and control, product characterization strategies, and data integration 
represent an ecosystem whose concerted advancement may reduce time-to-market and further improve 
comparability and biosimilarity programs. The NISTmAb, an IgG1k antibody generated against Respiratory 
Syncytial Virus (RSV), serves as a representative therapeutic like molecule for technology development with 
respect to production, purification and analytical characterization of the product. Three, non-originator cell lines 
expressing the NISTmAb were constructed to enable the development of downstream and upstream process.  
The products of the three cell lines and their similarities and differences from the NISTmAb will be presented. 
 
